Boston University_Site number 137 — Boston, Massachusetts

Boston University_Site number 137 is a clinical research site located in Boston, Massachusetts, United States 02118.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

Boston University_Site number 137 has participated in 1 clinical trials.

Therapeutic areas: System; Sclerosis, Diffuse Cutaneous Systemic Sclerosis.

Sponsors: Kadmon, a Sanofi Company.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Boston University_Site number 137?

Boston University_Site number 137 has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Boston University_Site number 137 conducted?

Boston University_Site number 137 has 1 clinical trials on record. Their work covers System; Sclerosis, Diffuse Cutaneous Systemic Sclerosis.

Is Boston University_Site number 137 accredited by Crixeo Health?

Boston University_Site number 137 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Boston University_Site number 137?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.